1.00

4.09% 0.0393

Pre-market: .99 -0.01 -1.00%

Lucid Diagnostics Inc (LUCD)

Overview News Price History Financials Discussions Forecast

Lucid Diagnostics Inc stock is traded at $1.00, with a volume of 921.59K. It is up +4.09% in the last 24 hours and up +0.90% over the past month. Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Previous Close:

$0.9607

Open:

$0.972

24h Volume:

921.59K

Relative Volume:

1.13

Market Cap:

$190.77M

Revenue:

$4.71M

Net Income/Loss:

$-58.01M

P/E Ratio:

-1.2145

EPS:

-0.8234

Net Cash Flow:

$-46.68M

1W Performance:

+4.37%

1M Performance:

+0.90%

6M Performance:

-9.91%

1Y Performance:

-22.48%

1-Day Range:

$0.972

$1.02

1-Week Range:

$0.95

$1.04

52-Week Range:

$0.90

$1.6293

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Name

Lucid Diagnostics Inc

Sector

Healthcare (1104)

Industry

Medical Devices (141)

Phone

212 949 4319

Address

360 MADISON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-05-15

Latest SEC Filings

LUCD's Discussions on Twitter

Compare LUCD vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LUCD Lucid Diagnostics Inc	1.00	190.77M	4.71M	-58.01M	-46.68M	-0.8234
ABT Abbott Laboratories	88.67	154.45B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	307.94	118.05B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	80.38	103.20B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	46.76	69.50B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.28	49.68B	6.30B	1.07B	1.09B	1.8406

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-27-21	Initiated	Ascendiant Capital Markets	Buy
Nov-08-21	Initiated	BTIG Research	Buy
Nov-08-21	Initiated	Cantor Fitzgerald	Overweight
Nov-08-21	Initiated	Needham	Buy

Lucid Diagnostics Inc Stock (LUCD) Latest News

Jun 08, 2026

Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2026. - marketscreener.com

Jun 08, 2026

Lucid Diagnostics misses on revenue, but 2026 growth outlook lights up bull case - MSN

Jun 08, 2026

Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case - Benzinga

Jun 08, 2026

LUCD Maintained by Ascendiant Capital -- Price Target Raised to $9.25 - GuruFocus

Jun 08, 2026

Jun 02, 2026

Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo Finance

Jun 02, 2026

Lucid Diagnostics Q1 2026 Earnings: EPS Miss Widens as Company Reports Wider-Than-Expected LossProfit Inflection Point - newsline.com

Jun 02, 2026

May 30, 2026

LUCD Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue Stage ChallengesRevenue Warning Signal - The Legal Advocate

May 30, 2026

May 29, 2026

LUCD Stock Price, Quote & Chart | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill

May 29, 2026

May 28, 2026

LUCD - Finviz

May 28, 2026

May 25, 2026

Lucid Diagnostics (LUCD) Surges 7% as Momentum Builds Near Key ResistanceTurnaround Stocks - The Legal Advocate

May 25, 2026

May 22, 2026

Lucid Diagnostics Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Firm Advances Commercial Rollout - The Legal Advocate

May 22, 2026

May 21, 2026

Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan

May 21, 2026

May 19, 2026

Lucid Diagnostics (LUCD) Rallies +1.30% as Bulls Target $1.02 2026-05-19Dividend Growth Stocks - The Legal Advocate

May 19, 2026

May 17, 2026

Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha

May 17, 2026